[1]
J. Y. Wang, N. Zhang, X. Yang, D. Gao, L. Yin, and S. Ji, “MHC class I-presented tumor antigen appraisable for T-cell responses against ovarian cancer”, Bangladesh J Pharmacol, vol. 10, no. 3, pp. 524–528, Jul. 2015.